ASKLEPIOS BIOPHARMACEUTICAL, INC.
CHAPEL HILL, NC, 27517-6040
|# of Employees:||N/A|
|Socially and Economically Disadvantaged:||N|
Abstract We propose to initiate preclinical development of a gene therapeutic targeted to Alzheimer's Disease. The World Health Organization's and Alzheimer's Disease International' ...STTRPhase I2014Department of Health and Human Services
DESCRIPTION (provided by applicant): This proposal seeks to leverage proprietary technical advances in Adeno-Associated Virus (AAV) vector mediated gene therapy to develop an AAV based Galanin gene de ...SBIRPhase I2008Department of Health and Human Services
DESCRIPTION (provided by applicant): This proposal intends to advance the regional delivery of a chimeric adeno-associated virus (rAAV)-based, highly-truncated dystrophin (minidystrophin) gene therapy ...SBIRPhase I2008Department of Health and Human Services
DESCRIPTION (provided by applicant): Repair of large structural bone defects remains a major problem in orthopaedic reconstruction surgery due to the limited supply of cortical bone autograft and the ...SBIRPhase I2005Department of Health and Human Services